RxDoctor Payments Data

Lacey Roybal, DO

Dermatology · Salem, ORNPI 1366977027

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.4% of the total across 381 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 34.5% of the total.

$8,540in general payments, 2019–2025

Across 381 payments — averaging $22.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Johnson & Johnson$1K
  • Novartis$949
  • Amgen$508
  • Lilly USA, LLC$415
  • Sanofi$376
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$7,89192%
  • Education$6498%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,540 in reported general payments places this provider in the 80th percentile of 175 dermatology providers in Oregon.

See all dermatology providers in Oregon

Medicare billing

Part B allowed, 2024
$184,841
Medicare patients
568
Services billed
5,643

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab38$445,596
Skyrizi PenRisankizumab-Rzaa13$284,276
Dupixent PenDupilumab45$178,212
Cosentyx Sensoready (2 Pens)Secukinumab12$89,361
Clobetasol Propionate110$5,871
Fluorouracil58$4,355
Tacrolimus22$2,895
Doxycycline Monohydrate72$2,151
Ketoconazole97$2,020
Triamcinolone Acetonide127$1,767
Clindamycin Phosphate21$962
Metronidazole13$829
Ciclopirox22$713
Hydroxychloroquine Sulfate22$702
Mometasone Furoate25$591

Paid to pharmacies, not to this prescriber.

Other dermatology in Salem

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →